BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12642874)

  • 1. Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.
    Tagliafico E; Siena M; Zanocco-Marani T; Manfredini R; Tenedini E; Montanari M; Grande A; Ferrari S
    Oncogene; 2003 Mar; 22(11):1712-23. PubMed ID: 12642874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human c-FES is a nuclear tyrosine kinase.
    Yates KE; Lynch MR; Wong SG; Slamon DJ; Gasson JC
    Oncogene; 1995 Mar; 10(6):1239-42. PubMed ID: 7700650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
    Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
    Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Fes kinase activity in myeloid cell growth and differentiation.
    Yates KE; Crooks GM; Gasson JC
    Stem Cells; 1996 Nov; 14(6):714-24. PubMed ID: 8948028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
    Lionberger JM; Smithgall TE
    Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal changes in the subcellular localization of the nuclear protein-tyrosine kinase, c-Fes.
    Carlson A; Yates KE; Slamon DJ; Gasson JC
    DNA Cell Biol; 2005 Apr; 24(4):225-34. PubMed ID: 15812239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells.
    Hackenmiller R; Simon MC
    Dev Biol; 2002 May; 245(2):255-69. PubMed ID: 11977979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
    Cheng H; Rogers JA; Dunham NA; Smithgall TE
    Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-dependent nuclear accumulation of the p94fer tyrosine kinase is regulated by its NH2 terminus and is affected by kinase domain integrity and ATP binding.
    Ben-Dor I; Bern O; Tennenbaum T; Nir U
    Cell Growth Differ; 1999 Feb; 10(2):113-29. PubMed ID: 10074905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
    Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U
    Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
    Cheng HY; Schiavone AP; Smithgall TE
    Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.
    Laurent CE; Delfino FJ; Cheng HY; Smithgall TE
    Mol Cell Biol; 2004 Nov; 24(21):9351-8. PubMed ID: 15485904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.
    Gnemmi I; Scotti C; Cappelletti D; Canonico PL; Condorelli F; Rosano C
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):18-20. PubMed ID: 17183165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.
    Read RD; Lionberger JM; Smithgall TE
    J Biol Chem; 1997 Jul; 272(29):18498-503. PubMed ID: 9218495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and structural analysis of murine c-fes cDNA clones.
    Wilks AF; Kurban RR
    Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
    Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
    Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of c-Fes in normal and neoplastic hematopoiesis.
    Yates KE; Gasson JC
    Stem Cells; 1996 Jan; 14(1):117-23. PubMed ID: 8820957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fer kinase/FerT and adherens junction dynamics in the testis: an in vitro and in vivo study.
    Chen YM; Lee NP; Mruk DD; Lee WM; Cheng CY
    Biol Reprod; 2003 Aug; 69(2):656-72. PubMed ID: 12700184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.